Tag: Health Care

Displaying 1 - 20 of 1151 results.

Pages

On June 18, 2019, the Federal Trade Commission will hold a public workshop in Washington, DC to assess the impact of certificates of public advantage (“COPAs”) on prices, quality, access, and innovation for healthcare services.
Following a public comment period, the Federal Trade Commission has approved a final order settling charges that Fresenius Medical Care AG’s proposed $2 billion acquisition of NxStage Medical, Inc. likely would be anticompetitive.
The Federal Trade Commission announced its Opinion and Final Order against generic pharmaceutical company Impax Laboratories LLC.
Federal Trade Commission staff has recommended that Alaska pass Senate Bill 1, which would repeal its certificate-of-need (CON) law. Alaska’s CON law requires healthcare providers to obtain state approval before expanding, establishing new facilities or services, or making certain large capital...
Federal Trade Commission Chairman Joe Simons released the agency’s 2018 Annual Highlights today, highlighting the FTC’s ongoing efforts to protect the interests of consumers and promote a competitive marketplace.
On June 18, 2019, the Federal Trade Commission will host a public workshop to assess the impact of certificates of public advantage (“COPAs”) on prices, quality, access, and innovation for healthcare services. This workshop is part of a broader COPA Assessment Project announced in...
The Federal Trade Commission will require healthcare companies Fresenius Medical Care AG & KGaA (Fresenius) and NxStage Medical, Inc. (NxStage) to divest all rights and assets related to NxStage’s bloodline tubing set business to B. Braun Medical, Inc. (B. Braun) as part of a settlement...
The Federal Trade Commission has approved an application by Teva to reopen and modify its decision and order in connection with the 2012 merger of Watson Pharmaceuticals, Inc. and Actavis Inc.
Using commercial claims for 2012-2013 from Colorado’s All-Payer Claims Database, we examine how medical service prices vary for five hospital-based procedures and the complexity adjusted inpatient price. We find that prices vary substantially in multiple dimensions. Our analysis...
The Federal Trade Commission has responded to the Food and Drug Administration’s request for comment on its revised draft guidance, which aims to deter pharmaceutical companies from abusing the citizen petition process to delay approval of and competition from generic drugs.
The Federal Trade Commission has issued a statement on its vote to close the investigation of a proposed transaction that would combine general acute care hospitals, a psychiatric hospital, and physician practices in eastern Massachusetts.

Pages